Mateusz Opyrchal, MD, PhD, Associate Director of the Early Phase Clinical Trials Program writes despite considerable advances and promising developments of late, metastatic breast cancer (mBC) continues to be a killer.
The impact and effectiveness of immunotherapy strategies for mBC treatment is an ongoing project. New strategies with powerful scientific underpinning are now in pursuit including a number of clinical trials at Roswell Park Comprehensive Cancer Center, Buffalo New York. Follow the link below to the source at Onclive to read more from Dr. Opyrchal’s important article.
Mateusz Ophychal, MD, PhD